{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:37:17Z","timestamp":1784309837648,"version":"3.55.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32-ES007060-31A1"],"award-info":[{"award-number":["T32-ES007060-31A1"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources Services Administration","doi-asserted-by":"crossref","award":["D34HP31025"],"award-info":[{"award-number":["D34HP31025"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1080\/02791072.2023.2178558","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T13:09:16Z","timestamp":1677676156000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients"],"prefix":"10.1080","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-8097","authenticated-orcid":false,"given":"Alexia G.","family":"Aguilar","sequence":"first","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burke A.","family":"Beauregard","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-8690","authenticated-orcid":false,"given":"Christopher P.","family":"Conroy","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashoda T.","family":"Khatiwoda","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantia M. E.","family":"Horsford","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of New England, Portland, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2295-445X","authenticated-orcid":false,"given":"Brian J.","family":"Piper","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA"},{"name":"Center for Pharmacy Innovation & Outcomes, Danville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.003"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.06.012"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.1.16"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17f11738"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000142"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.09.083"},{"key":"e_1_3_6_8_1","unstructured":"Brezina K. 2017. ELEKT-D: Electroconvulsive Therapy (ECT) vs. ketamine in patients with treatment resistant depression (TRD)Vol. NCT03113968. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03113968"},{"key":"e_1_3_6_9_1","unstructured":"Clin Calc. The top 300 of 2019. Accessed May 6 2022. https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx."},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.086"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2019.01.048"},{"key":"e_1_3_6_12_1","unstructured":"Dodd E. and M. DeSilva 2018. Ketamine versus electroconvulsive therapy in depression. NCT03674671. Accessed February 17 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03674671"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14344.1"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2034954"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.239228"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118760660"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.30802\/AALAS-CM-18-000053"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20081001-05"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2018.11.007"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.03.026"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx035"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03601-8"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20081251"},{"key":"e_1_3_6_24_1","unstructured":"Medicaid. 2022. State drug utilization data. Accessed February 17 2023. https:\/\/www.medicaid.gov\/medicaid\/prescription-drugs\/state-drug-utilization-data\/index.html"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13030392"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1229.87287"},{"key":"e_1_3_6_27_1","unstructured":"Pharmacoeconomic report: Esketamine hydrochloride (Spravato): (Janssen Inc.): Indication: major depressive disorder in adults. 2021. Appendix 1 Cost Comparison Table. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health Apr. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572205."},{"key":"e_1_3_6_28_1","unstructured":"Qiu Y. and G. Du 2020. The effect of S-ketamine for patients undergoing electroconvulsive therapy (ECT). NCT04399070."},{"key":"e_1_3_6_29_1","unstructured":"Retraction Watch. The Retraction Watch Database. 2022. New York: The Center for Scientific Integrity Accessed January 2 2022. http:\/\/retractiondatabase.org\/."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900625"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30272-9"},{"key":"e_1_3_6_32_1","unstructured":"U.S. Department of Health and Human Services. 2022. Suicide. National Institute of Mental Health. Accessed February 11 2022. https:\/\/www.nimh.nih.gov\/health\/statistics\/suicide."},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m13886"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7024e1externalicon"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.12.010"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.11.033"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2023.2178558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T07:47:25Z","timestamp":1709797645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2023.2178558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1080\/02791072.2023.2178558"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2023.2178558","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.23.22274206","asserted-by":"object"}]},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}